Injections and return to play

Current Pain and Headache Reports

Volumn 9, Issue 1, 2005, Pages 11-16

  Dietzel, Douglas P ^a   Hedlund, Eric C ^b  

^a Michigan Orthopedic Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; CORTICOSTEROID; HYALURONIC ACID; KETOROLAC TROMETAMOL; LIDOCAINE; PLACEBO; NONSTEROID ANTIINFLAMMATORY AGENT;

ABSCESS; ADRENAL CORTEX INSUFFICIENCY; ANAPHYLAXIS; ARTHROPATHY; ATHLETE; BLEEDING; BLOOD VESSEL INJURY; CHONDROPATHY; COMPETITION; DISEASE COURSE; DRUG CONTRAINDICATION; DRUG SAFETY; DRUG TOLERABILITY; DRUG UTILIZATION; FOOTBALL; GASTROINTESTINAL DISEASE; GRANULOMATOUS INFLAMMATION; HEALING; HUMAN; HYPERGLYCEMIA; INFECTION; INFLAMMATION; INJECTION PAIN; INJECTION SITE REACTION; JOINT EFFUSION; KIDNEY FAILURE; LIGAMENT DISEASE; MEDICAL DECISION MAKING; MUSCLE INJURY; NEURITIS; NONHUMAN; OCCUPATIONAL ACCIDENT; OSTEOARTHRITIS; PAIN; PLAY; RABBIT; REVIEW; RISK ASSESSMENT; RUGBY; SICKLE CELL CRISIS; SKIN ATROPHY; SYNOVITIS; TENDINITIS; TENDON DISEASE; TENDON RUPTURE; TIME; TREATMENT OUTCOME; WORK RESUMPTION; ANIMAL; INJECTION; METHODOLOGY; SPORT; SPORTS MEDICINE;

ADRENAL CORTEX HORMONES; ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; HUMANS; HYALURONIC ACID; INJECTIONS; KETOROLAC TROMETHAMINE; SPORTS; SPORTS MEDICINE;

EID: 14044270752     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-005-0069-5     Document Type: Review

References (50)

1. Hollander JL, Brown EM, Jessar RA: Hydrocortisone and cortisone injected into arthritic joints. JAMA 1951, 147: 629-1635.
2. Fadale PD, Wiggins ME: Corticosteroid injections: their use and abuse. J Am Acad Orthop Surg 1994, 2:133-140.
3. Kerlan RK, Glousman RE: Injections and techniques in athletic medicine. Clinics in Sports Med 1989, 3:541-560.
4. Fredberg U: Local corticosteroid injection in sport: review of literature and guidelines for treatment. Scand J Med Sci Sports 1997, 7:131-139.
5. Charalambous C, Paschalides C, Sadiq S, et al.: Weight bearing following intra-articular steroid injection of the knee: survey of current practice and review of the available evidence. Rheumatol Int 2002, 22:185-187.
6. Mankind HJ, Conger KA: The acute effects of intra-articular hydrocortisone on articular cartilage in rabbits. J Bone Joint Surg Am 1966, 48:1383-1388.
7. Pelletier JP, Martel-Pelletier J: Protective effects of corticosteroids on cartilage lesions and osteophyte formation in the Pond-Nuki dog model of osteoarthritis. Arthritis Rheum 1989, 32:181-193.
8. Behrens F, Shepard N, Mitchell N: Metabolic recovery of articular cartilage after intra-articular injections of glucocorticoid J Bone Joint Surg Am 1976, 58:1157-1160.
9. Balch HW, Gibson JMC, El-Ghobarey AF: Repeated corticosteroid injections into knee joints. Rheumatol Rehab 1977, 16:137-140.
10. Ishikawa K: Effect of intra-articular corticosteroid on the meniscus: A histological and histochemical study in rabbit knees. J Bone Joint Surg Am 1981, 63:120-130.
11. Noyes FR, Grood ES, Nussbaum NS, et al.: Effect of intra-articular corticosteroids on ligament properties: a biomechanical and histological study in rhesus knees. Clin Orthop 1977, 123:197-209.
12. Wiggins M, Fadale P, Barrach H, et al.: Long term effects of corticosteroid treatment on a healing rabbit medial collateral ligament. Trans Orthop Res Soc 1994, 18:59.
13. Wiggins M, Fadale F, Russell M, et al.: Effects of delayed steroid injection on ligament healing. Trans Orthop Res Soc 1994, 19:633.
14. Balasubramaniam P, Prathap K: The effect of injection of hydrocortisone into rabbit calcaneal tendons. J Bone Joint Surg BR 1972, 54:729-734.
15. Kennedy JC, Baxter R: The effects of local steroid injections on tendon: a biomechanical and microscopic correlative study Am J Sports Med 1976, 4:11-21.
16. McWhorter W, Francis RS, Heckmann RA: Influence of local steroid injections on traumatized tendon properties: a biomechanical and histological study. Am J Sports Med 1991, 19:435-439.
17. Orchard JW: Benefits and risks of using local anaesthetic for pain relief to allow early return to play in professional football Br J Sports Med 2002, 36:209-213.
18. Tokish JM, Powell ET, Schlagel TF, Hawkins RJ: Ketorolac use in the National Football League. Physician Sports Med 2002, 9.
19. Pasloske K, Burger J, Conlon P: Plasma prostaglandin E2 concentrations after single dose administration of Ketorolac tromethamine (Toradol) in dogs. Can J Vet Res 1998, 62:237-240.
20. Milne JC, Russell JA, Woods GW, Dalton MD: Effect of Ketorolac tromethamine (Toradol) on Ecchymosis following anterior cruciate ligament reconstruction. Am J Knee Surg 1995, 1: 4-27.
21. Concannon MJ, Meng L, Welsh CF, Puckett CL: Inhibition of Perioperative platelet aggregation using Toradol (Ketorolac). Ann Plastic Surg 1993, 3:264-266.
22. Feldman HI, Kinman JL, Berlin JA, et al.: Parenteral Ketorolac: the risk for acute renal failure. Ann Intern Med 1997, 126:193-199.
23. Fraser JRE, Clarris BJ, Baxter EP: Patterns of inducted variation in morphology, hyaluronic acid secretion, and lysosomal enzyme activity of cultured human synovial cells. Ann Rheum Dis 1979, 38:287-294.
24. Gibbs DA, Merrill EW, Smith KA, et al.: Rheology of hyaluronic acid. Biopolymers 1968, 6:777-791.
25. Balazs EA, Denlinger JL: Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol 1993, 20(Suppl 39):3-9.
26. Marshall KW. Viscosupplementation for osteoarthritis: current status, unresolved issues and future directions. J Rheumatol 1998, 25:2056-2058.
27. Brandt KD, Smith GN, Simon LS: Intraarticular injection of hyaluronan as treatment for knee osteoarthritis. Arthritis Rheum 2000, 43:1192-1203.
28. Ghosh P: The role of hyaluronic acid (hyaluronan) in health and disease: interactions with cells, cartilage and components of synovial fluid. Clin Exp Rheumatol 1994, 12:75-82.
29. Hyalgan (sodium hyaluronate) prescribing information. Sanofi-Synthelabo; New York, NY.
30. Supartz (sodium hyaluronate) prescribing information. Seikagaku; Tokyo, Japan.
31. Synvisc (hylan G-F 20) prescribing information. Wyeth Pharmaceuticals; Madison, NJ.
32. Orthovisc (sodium hyaluronate) prescribing information. Anika Therapeutics; Woburn, MA.
33. Balazs EA, Denlinger JL: Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol 1993, 20(Suppl 39):3-9.
34. Wobig M, Bach G, Beks F, et al.: The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan. Clin Ther 1999, 21: 549-1562.
35. Lohmander LS, Dalen N, Englund G, et al.: Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomized double blind, placebo controlled multicenter trial. Ann Rheum Dis 1996, 55:424-431.
36. Dougados M, Nguyen M, Listrat V, et al.: High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthritis Cartilage 1993, 1:97-103.
37. Puttick MP, Wade JP, Chalmers A, et al.: Acute local reactions after intraarticular hylan for osteoarthritis of the knee. J Rheumatol 1995, 22:1311-1314.
38. Wright JM, Crockett HG, Dowd M: The role of viscosupplementation for osteoarthritis of the knee. Orthop Spec Ed 2001, 7:15-18.
39. Chen AL, Desai P, Adler EM, et al.: Granulomatous Inflammation after Hylan G-F 20 viscosupplementation of the knee. J Bone Joint Surg 2002, 84:1142-1147.
40. Zardawi IM, Chan I: Synvisc perisynovitis. Pathology 2001, 33:519-520.
41. Leopold SS, Warme WJ, Pettis PD, et al.: Increased frequency of acute local reaction to intra-articular Hylan GF-20 (Synvisc) in patients receiving more than one course of treatment. J Bone Joint Surg 2002, 84:1619-1623.
42. Wobig M, Dickhyt A, Maier R, et al.: Viscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee. Cin Ther 1998, 20:410-423.
43. Henderson EB, Smith EC, Pegley F, et al.: Intra-articular injections of 750 kD hylaronan in the treatment of osteoarthritis: a randomized single center double-blind placebo-controlled trial of 91 patients demonstrating lack of efficacy Ann Rheum Dis 1994, 53:529-534.
44. Puhl W, Bernau A, Greiling H, et al.: Intra-articular sodium hyaluronate in osteoarthritic of the knee: a multicenter, double blind study. Osteoarthritis Cartilage 1993, 1:233-241.
45. Jones AC, Patrick M, Doherty S, et al.: Intra-articular hyaluronic acid compared to intra-articular triamcinolone hexacetonide in inflammatory knee osteoarthritis. Osteoarthritis Cartilage 1995, 3:269-273.
46. Adams ME, Atkinson MH, Lussier AJ, et al.: The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone hylan G-F 20 with NSAIDs and NSAIDs alone. Osteoarthritis Cart 1995, 3:213-225.
47. Pleimann JH, Davis WH, Cohen BE, et al.: Viscosupplementation for the arthritic ankle. Foot Ankle Clin 2002, 7:489-494.
48. Brocq O, Tran G, Breil V, et al.: Hip osteoarthritis: short-term efficacy and safety of viscosupplementation by hylan G-F 20. An open-label study in 22 patients. Joint Bone Spine 2002, 69:388-391.
49. Williams JM, Rayan V, Sumner DR, et al.: The use of intra-articular Na-hyaluronate as a potential chondroprotective device in experimentally induced acute articular cartilage injury and repair in rabbits. J Orthop Res 2003, 21:305-311.
50. Adams ME, Brandt KD: Hypertrophic repair of canine articular cartilage in osteoarthritis after anterior cruciate ligament transaction. J Rheumatol 1991, 18:428-435.